↓ Skip to main content

Outcomes of salvage therapy for steroid‐refractory acute severe ulcerative colitis: ciclosporin vs. infliximab

Overview of attention for article published in Alimentary Pharmacology & Therapeutics, June 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy
1 policy source
twitter
12 X users
facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Outcomes of salvage therapy for steroid‐refractory acute severe ulcerative colitis: ciclosporin vs. infliximab
Published in
Alimentary Pharmacology & Therapeutics, June 2013
DOI 10.1111/apt.12375
Pubmed ID
Authors

A. Croft, A. Walsh, J. Doecke, R. Cooley, M. Howlett, G. Radford‐Smith

Abstract

Up to 40% of patients who present with acute severe ulcerative colitis (UC) fail to make an adequate response to intravenous corticosteroids. Ciclosporin or infliximab are currently employed as salvage therapy in this clinical scenario.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
South Africa 1 1%
Unknown 74 97%

Demographic breakdown

Readers by professional status Count As %
Other 9 12%
Student > Postgraduate 8 11%
Student > Master 8 11%
Researcher 7 9%
Professor > Associate Professor 7 9%
Other 22 29%
Unknown 15 20%
Readers by discipline Count As %
Medicine and Dentistry 44 58%
Agricultural and Biological Sciences 4 5%
Computer Science 2 3%
Social Sciences 2 3%
Nursing and Health Professions 1 1%
Other 9 12%
Unknown 14 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2021.
All research outputs
#3,221,884
of 25,371,288 outputs
Outputs from Alimentary Pharmacology & Therapeutics
#1,098
of 5,632 outputs
Outputs of similar age
#26,802
of 209,222 outputs
Outputs of similar age from Alimentary Pharmacology & Therapeutics
#13
of 64 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,632 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,222 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.